Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome

被引:47
作者
Bernstein, HG
Bukowska, A
Krell, D
Bogerts, B
Ansorge, S
Lendeckel, U
机构
[1] Otto Von Guericke Univ, Psychiat Klin, D-39120 Magdeburg, Germany
[2] Otto Von Guericke Univ, Psychotherapie & Psychosomat Med Klin Expt Innere, Fak Med, D-39120 Magdeburg, Germany
[3] Otto Von Guericke Univ, Inst Med Technol Magdeburg, D-39120 Magdeburg, Germany
来源
JOURNAL OF NEUROCYTOLOGY | 2003年 / 32卷 / 02期
关键词
D O I
10.1023/B:NEUR.0000005600.61844.a6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Using immunohistochemical techniques we studied the light microscopic localization of ADAMs ( A Disintegrin And Metalloprotease) 10 and 15 in different neocortical areas of the human brain during normal aging, and also in patients with Alzheimer disease ( AD) and Down syndrome (DS). ADAM 10, a putative alpha-secretase involved in Notch signaling, was found in neurons of the perinatal cortex. During aging there is an increase in intraneuronal staining intensity and in the number of cortical nerve cells that contain the enzyme. Furthermore, in AD and DS brains ADAM 10 immunoreactivity was associated with diffuse and neuritic plaques. ADAM 15 was detected in perinatal cortical pyramidal cells; during aging there was also an increase in intracellular staining and the number of stained cells per volume ( cell density). In AD brains ADAM15 was seen in a few diffuse plaques. Morphometric analysis revealed a significant reduction of ADAM 10 but not ADAM 15 immunoreactive neurons in AD brains in comparison to controls. Our findings support the idea that ADAM 10 is involved in the pathophysiology of AD and DS. ADAM 15 might be linked to AD via interaction with integrin and/or src protein tyrosine kinases.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 41 条
  • [1] Altered expression of ADAMS (A Disintegrin And Metalloproteinase) in fibrillating human atria
    Arndt, M
    Lendeckel, U
    Röcken, C
    Nepple, K
    Wolke, C
    Spiess, A
    Huth, C
    Ansorge, S
    Klein, HU
    Goette, A
    [J]. CIRCULATION, 2002, 105 (06) : 720 - 725
  • [2] The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease - A review
    Bernstein, HG
    Kirschke, H
    Wiederanders, B
    Pollak, KH
    Zipress, A
    Rinne, A
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 27 (03) : 225 - 247
  • [3] IMMUNOLOCALIZATION OF DIPEPTIDYL AMINOPEPTIDASE (DAP-IV) IN THE DEVELOPING HUMAN-BRAIN
    BERNSTEIN, HG
    SCHON, E
    ANSORGE, S
    ROSE, I
    DORN, A
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1987, 5 (03) : 237 - +
  • [4] INCREASED IMMUNOSTAINING FOR L-ORNITHINE DECARBOXYLASE OCCURS IN NEOCORTICAL NEURONS OF ALZHEIMERS-DISEASE PATIENTS
    BERNSTEIN, HG
    MULLER, M
    [J]. NEUROSCIENCE LETTERS, 1995, 186 (2-3) : 123 - 126
  • [5] BERNSTEIN HG, 1995, NEUROSCI LETT, V263, P161
  • [6] Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists
    Bi, X
    Gall, CM
    Zhou, J
    Lynch, G
    [J]. NEUROSCIENCE, 2002, 112 (04) : 827 - 840
  • [7] Remarkable roles of proteolysis on and beyond the cell surface
    Blobel, CP
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (05) : 606 - 612
  • [8] Bosse F, 2000, GLIA, V32, P313, DOI 10.1002/1098-1136(200012)32:3<313::AID-GLIA100>3.0.CO
  • [9] 2-G
  • [10] Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients
    Braunewell, KH
    Riederer, P
    Spilker, C
    Gundelfinger, ED
    Bogerts, B
    Bernstein, HG
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (02) : 110 - 116